No evidence of efficacy or evidence of no efficacy

JAMA Pediatrics

Volumn 167, Issue 3, 2013, Pages 300-302

  Arruda, Marco A ^a  

^a Glia Institute   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; IBUPROFEN; PARACETAMOL; PLACEBO; RIZATRIPTAN; TOPIRAMATE; TRAZODONE; TRIPTAN DERIVATIVE;

DRUG APPROVAL; DRUG EFFICACY; EDITORIAL; HUMAN; MIGRAINE; PARALLEL DESIGN; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ANALGESICS; HEADACHE; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 84874928691     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.1105     Document Type: Editorial

References (15)

1. Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Frequent headaches in the preadolescent pediatric population: a population-based study. Neurology. 2010;74(11):903-908.
2. Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088-1097.
3. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology. 2006;67(2):246-251. (Pubitemid 44305407)
4. Arruda MA, Bordini CA, Ciciarelli MC, Speciali JG. Decreasing the minimal duration of the attack to 1 hour: is this sufficient to increase the sensitivity of the ICHD-II diagnostic criteria for migraine in childhood? J Headache Pain. 2004; 5(2):131-136. doi:10.1007/s10194-004-0081-x. (Pubitemid 39199677)
5. Balottin U, Termine C. Recommendations for the management of migraine in paediatric patients. Expert Opin Pharmacother. 2007;8(6):731-744. (Pubitemid 46736452)
6. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron. 2007;55(2):325-336. (Pubitemid 47048908)
7. Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents [published online January 28, 2013]. JAMA Pediatr. 2013;167(3):243-249.
8. Ho TW, Pearlman E, Lewis D, et al Rizatriptan Protocol 082 Pediatric Migraine Study Group. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012;32(10):750-765.
9. El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis [published online January 28, 2013]. JAMA Pediatr. 2013;167(3):250-258.
10. Tfelt-Hansen PC, Olesen J. Publication committees in clinical trials in headache. Cephalalgia. 2012;32(1):86.
11. Fonagy P. What is the place of psychodynamic psychotherapy and cognitivebehaviour therapy in child and adolescent psychiatry? Presented at: Proceedings of the 12th International Congress European Society for Child and Adolescence Psychiatry. 2003; Paris, France.
12. Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112(1, pt 1):e1-e5.
13. Arruda MA, Bigal ME. Behavioral and emotional symptoms and primary headaches in children: a population-based study. Cephalalgia. 2012;32(15):1093-1100.
14. Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology. 2012;79(18):1881-1888.
15. Galli F, Canzano L, Scalisi TG, Guidetti V. Psychiatric disorders and headache familial recurrence: a study on 200 children and their parents. J Headache Pain. 2009;10(3):187-197.